63
Participants
Start Date
May 31, 2011
Primary Completion Date
October 31, 2014
Study Completion Date
October 31, 2014
BKM120
Buparlisib was supplied as 10mg or 50mg capsules. It was administered on a continuous once daily dosing schedule at a dose of 100 mg. The patient was dosed on a flat scale of mg/day and not adjusted to body weight or body surface area.
Novartis Investigative Site, Taipei
Novartis Investigative Site, Tainan City
Novartis Investigative Site, Brussels
Novartis Investigative Site, Budapest
Novartis Investigative Site, Budapest
Novartis Investigative Site, Leuven
Novartis Investigative Site, Mátraháza
Novartis Investigative Site, Genk
Novartis Investigative Site, Charleroi
Novartis Investigative Site, Deszk
Novartis Investigative Site, Libramont
Novartis Investigative Site, Rio Negro
Novartis Investigative Site, Bangkok
Novartis Investigative Site, Berlin
Novartis Investigative Site, Marseille
Novartis Investigative Site, Caen
Roswell Park Cancer Institute Rosewell, Buffalo
University of Pittsburgh Medical Center SC-2, Pittsburgh
Novartis Investigative Site, Genova
Novartis Investigative Site, Milan
Novartis Investigative Site, Milan
Novartis Investigative Site, Großhansdorf
Virginia Oncology Associates VOA - Lake Wright (2), *see Various Departments*
Novartis Investigative Site, Oldenburg
Duke University Medical Center Duke 2, Durham
Medical University of South Carolina MUSC, Charleston
Emory University School of Medicine/Winship Cancer Institute Emory 2, Atlanta
Novartis Investigative Site, Udine
H. Lee Moffitt Cancer Center & Research Institute H Lee Moffitt, Tampa
Novartis Investigative Site, Altunizade
Novartis Investigative Site, Izmir
Novartis Investigative Site, Parma
Novartis Investigative Site, Essen
Novartis Investigative Site, Recklinghausen
Karmanos Cancer Institute Wayne St Karmanos, Detroit
Novartis Investigative Site, Chiang Mai
Novartis Investigative Site, Cologne
University of Wisconsin Univ WIsc 2, Madison
Rush University Medical Center SC, Chicago
University of Chicago Medical Center Unvi Chi, Chicago
Washington University School of Medicine Washington University (16), St Louis
University of Kansas Cancer Center Univ of KS, Kansas City
Novartis Investigative Site, Heidelberg
Highlands Oncology Group Dept of Highlands Oncology Grp, Fayetteville
University of Oklahoma Health Sciences Center Dept. of Oklahoma Univ. HSC, Oklahoma City
Baylor Health Care System/Sammons Cancer Center Baylor Texas Oncology, Dallas
Texas Oncology South Texas Oncology, Dallas
University of Colorado Univ CO, Aurora
Rocky Mountain Cancer Centers Dept. of Rocky Mountain Cancer, Greenwood Village
Novartis Investigative Site, Gauting
Novartis Investigative Site, Avellino
Ironwood Cancer and Research Centers SC, Chandler
Mayo Clinic - Arizona Mayo Scottsdale AZ, Scottsdale
Memorial Sloan Kettering Cancer Center Sloan Kettering, New York
Cedars Sinai Medical Center Dept.of Cedars-Sinai Med. Ctr., Los Angeles
Novartis Investigative Site, Nuremberg
University of California at San Diego, Moores Cancer Ctr SC, San Diego
Novartis Investigative Site, Créteil
Novartis Investigative Site, Villejuif
Northwest Cancer Specialists Compass Oncology -BKM, Portland
Novartis Investigative Site, Singapore
Arizona Oncology Associates Tucson (Rudasill & La Cholla), Phoenix
Novartis Investigative Site, Hong Kong
Massachusetts General Hospital Mass General, Boston
Fallon Clinic at Worcester Medical Center Fallon Clinic Worcester Med, Worcester
Hematology Oncology Associates of Northern New Jersey PA DeptofHem-OncofNorthern NJ (2), Morristown
Overlook Hospital - Carol G Simon Cancer Center Carol G Simon, Summit
MetroHealth Medical Center Dept.ofMetroHealthMedCtr.(2), Cleveland
U of TX Southwestern Medical Center - SimmonsCompCancerCtr Clinical Research Office, Dallas
Novartis Investigative Site, Buenos Aires
Novartis Investigative Site, Córdoba
Novartis Investigative Site, Salvador
Novartis Investigative Site, Rio de Janeiro
Novartis Investigative Site, Florianópolis
Novartis Investigative Site, Barretos
Novartis Investigative Site, São Paulo
Novartis Investigative Site, Vancouver
Novartis Investigative Site, Toronto
Novartis Investigative Site, Montreal
Novartis Investigative Site, Rennes
Novartis Investigative Site, Szolnok
Novartis Investigative Site, Kurashiki
Novartis Investigative Site, Koto
Novartis Investigative Site, Maastricht
Novartis Investigative Site, Sabadell
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Mataró
Novartis Investigative Site, Alicante
Novartis Investigative Site, Northwood
Novartis Investigative Site, Leicester
Novartis Investigative Site, London
Novartis Investigative Site, Manchester
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY